- ￥600 - 1699
- Sino Biological
- 北京
- 40280-RP01
- 2025年08月12日
- ELISA
- Rabbit
- HCV
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Hepatitis C virus (HCV-1a) E2 Protein (Catalog#40280-V08H)
- 亚型：
Rabbit IgG
- 形态：
液体
- 保存条件：
-20℃ to -80℃
- 克隆性：
兔多抗
- 适应物种：
HCV
- 保质期：
12个月
- 抗原来源：
40280-V08H
- 目录编号：
40280-RP01
- 级别：
免疫学试剂
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 宿主：
Rabbit
- 应用范围：
ELISA
- 浓度：
ELISA: 1:1000-1:2000
- 靶点：
HCV-E2
- 抗体英文名：
Hepatitis C virus (HCV-1a) E2 Antibody, Rabbit PAb
- 抗体名：
Hepatitis C virus (HCV-1a) E2 Antibody, Rabbit PAb
- 规格：
20 µL/100 µL
| 规格： | 20 µL | 产品价格： | ￥600.0 |
|---|---|---|---|
| 规格： | 100 µL | 产品价格： | ￥1699.0 |
HCV-E2|HCV-E2 antibody|HCV-E2抗体|Anti-HCV 兔多抗（产品说明）
抗体种属：HCV
抗体靶点：HCV-E2
抗体应用：ELISA
抗原货号：40280-V08H
抗原描述：Recombinant Hepatitis C virus (HCV-1a) E2 Protein (Catalog#40280-V08H)
抗体宿主：Rabbit
抗体Ig类型：Rabbit IgG
抗体纯化方法：Protein A
抗体制备：Produced in rabbits immunized with purified, recombinant Hepatitis C virus (HCV-1a) E2 ( Catalog#40280-V08H; NP_751921.1; Glu1-Glu278). Total IgG was purified by Protein A affinity chromatography.
抗体特异性：Hepatitis C virus (HCV-1a) E2
抗体保存：This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Hepatic carcinogenesis is a complex process that involves profound alterations of the hepatocyte genome (1,2) and has been graded in three stages: induction, promotion, and progression in the animal models (3–5). In recent years, the use
Nomenclature and Numbering of the Hepatitis C Virus
International standardization and coordination of the nomenclature of variants of hepatitis C virus (HCV) is increasingly needed as more is discovered about the scale of HCV-related liver disease and important biological and antigenic
Detection and Typing of Hepatitis C Virus
For more than two decades prior to the discovery of the hepatitis C virus (HCV), posttransfusion non-A, non-B (NANB) hepatitis was thought to have a viral etiology. In 1989, the virus was finally identified through a unique application
技术资料暂无技术资料 索取技术资料
